Review: Side Effects of Approved Molecular Targeted Therapies in Solid Cancers-Reference-Cited by-同舟云学术

Review: Side Effects of Approved Molecular Targeted Therapies in Solid Cancers

Published:2007-12-01 Issue:12 Volume:12 Page:1443-1455
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Widakowich Christian¹²,de Castro Gilberto³,de Azambuja Evandro¹²,Dinh Phuong¹,Awada Ahmad¹²

Affiliation:

1. a Medical Oncology Clinic, Institut Jules Bordet, Brussels, Belgium

2. b Université Libre de Bruxelles, Brussels, Belgium

3. c Clinical Oncology Service, Hospital das Clinicas, University of Sao Paulo Medical School, Sao Paulo, Brazil

Abstract

Learning Objectives After completing this course, the reader will be able to: List the molecular targeted agents that are considered standard practice in solid tumors.Differentiate among the side effects of commonly used molecular targeted agents.Better characterize the side effects of molecular targeted agents. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-12-1443

Reference114 articles.

1. Comparing antibody and small-molecule therapies for cancer;Imai;Nature,2006

2. Targeted cancer therapy;Sawyers;Nature,2004

3. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor;Chen;Nature,1987

4. The EGF receptor: An essential regulator of multiple epidermal functions;Jost;Eur J Dermatol,2000

5. Epidermal growth factor receptor inhibitor–associated cutaneous toxicities: An evolving paradigm in clinical management;Lynch;The Oncologist,2007

Cited by 287 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review;International Journal of Nanomedicine;2024-09

2. DEVELOPMENT AND OPTIMIZATION OF SUPER SATURABLE SELF-NANO EMULSIFYING DRUG DELIVERY SYSTEM FOR DASATINIB BY DESIGN OF EXPERIMENT;International Journal of Applied Pharmaceutics;2024-05-07

3. Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma;Journal for ImmunoTherapy of Cancer;2024-05

4. Engineered oncolytic bacteria for malignant solid tumor treatment;Interdisciplinary Medicine;2024-04

5. Induction of Arterial Inflammation by Immune Checkpoint Inhibitor Therapy in Lung Cancer Patients as Measured by 2-[18F]FDG Positron Emission Tomography/Computed Tomography Depends on Pre-Existing Vascular Inflammation;Life;2024-01-19